ASCENSIA DIABETES CARE US INC

Ascensia Diabetes Care US Inc. specializes in the manufacturing of in-vitro diagnostic substances, including reagents, test kits, and test sets designed for glucose monitoring and diabetes management. Their technical expertise lies in the development and production of clinically validated diagnostic platforms that support point-of-care and self-monitoring applications, with a focus on precision, reliability, and regulatory compliance for medical devices. The company’s core differentiators include proprietary assay technologies, quality-controlled manufacturing processes aligned with FDA and ISO standards, and the ability to deliver scalable diagnostic solutions tailored to clinical and home-use environments. Their products are engineered for integration into broader healthcare ecosystems, ensuring compatibility with digital health platforms and patient management systems. The contractor has demonstrated direct engagement with the Department of Veterans Affairs, providing diagnostic test kits and reagents under Federal Supply Schedule contracts to support veteran healthcare services. This relationship reflects a consistent alignment with VA’s mission to deliver accessible, high-quality diabetes care through reliable diagnostic tools at VA medical centers and community-based outpatient clinics. Ascensia operates primarily within NAICS 325413, which encompasses the manufacturing of in-vitro diagnostic substances used in clinical laboratories and patient self-testing. Their market positioning is centered on diabetes care diagnostics, serving a critical niche within the broader medical device and point-of-care testing industry. They focus on consumable diagnostic products that enable continuous monitoring and data-driven clinical decisions. As a 2L entity headquartered in Parsippany, New Jersey, Ascensia Diabetes Care US Inc. is structured as a subsidiary of a larger international organization. While no specific government certifications are listed, their compliance with FDA regulations and adherence to quality management systems underpin their eligibility for federal procurement. Their geographic presence and operational focus are aligned with U.S. federal healthcare supply chains, particularly in the delivery of essential diagnostic consumables to government medical facilities.